Penn Therapeutics, CRS — Philadelphia, Pennsylvania

Penn Therapeutics, CRS is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Penn Therapeutics, CRS has participated in 20 clinical trials with 1 currently active.

Therapeutic areas: HIV Infections, Sexually Transmitted Diseases, Cytomegalovirus Infections.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Penn Therapeutics, CRS?

Penn Therapeutics, CRS has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Penn Therapeutics, CRS conducted?

Penn Therapeutics, CRS has 20 clinical trials on record, with 1 currently active. Their work covers HIV Infections, Sexually Transmitted Diseases, Cytomegalovirus Infections.

Is Penn Therapeutics, CRS accredited by Crixeo Health?

Yes — Penn Therapeutics, CRS holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Penn Therapeutics, CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.